Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma
Article first published online: 23 JUN 2009
© 2009 Japanese Cancer Association
Volume 100, Issue 10, pages 1908–1916, October 2009
How to Cite
Begum, A., Imoto, I., Kozaki, K.-i., Tsuda, H., Suzuki, E., Amagasa, T. and Inazawa, J. (2009), Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. Cancer Science, 100: 1908–1916. doi: 10.1111/j.1349-7006.2009.01252.x
- Issue published online: 14 SEP 2009
- Article first published online: 23 JUN 2009
- (Received May 12, 2009/Revised June 4, 2009/Accepted June 4, 2009/Online publication July 7, 2009)
- 1Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108., , ,
- 2Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 2006; 18: 228–33., .
- 3Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006; 7: 77–82., .
- 4Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol 2008; 44: 369–82., , et al .
- 5Oncogene amplification in solid tumors. Semin Cancer Biol 1999; 9: 319–25.
- 6Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett 2001; 167: 115–23.,
- 7High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207–11., , et al .
- 8Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004; 95: 559–63., ,
- 9PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene 2007; 26: 7921–32., , et al .
- 10AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 1992; 89: 9267–71., , et al .
- 11Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994; 91: 2156–60., , et al .
- 12Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 1995; 64: 280–5., , et al .
- 13Targeting group II PAKs in cancer and metastasis. Cancer Metastasis Rev 2009; 28: 209–17., ,
- 14Japan Society for Head and Neck Cancer. General Rules for Clinical Studies on Head and Neck Cancer, 3rd edn. Tokyo: Kanahara, 2001.
- 15International Union Against Cancer (UICC). TNM Classification of Malignant Tumours, 6th edn. New York: Wiley–Liss, 2002; 19–52., In:
- 16Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma. Am J Pathol 2004; 165: 71–81., , et al .
- 17Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 2002; 277: 550–8., , et al .
- 18MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines. Oncogene 1999; 18: 7975–84., , et al .
- 19High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000; 157: 787–94., , et al .
- 20Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines. Cancer Res 2002; 62: 7157–61., , et al .
- 21The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma. Cancer Res 2006; 66: 4149–58., , et al .
- 22The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene 2006; 25: 3247–57., , et al .
- 23Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer Res 2007; 67: 1943–9., , et al .
- 24Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res 2008; 14: 5348–56., , et al .
- 25Cancer: addiction to oncogenes – The Achilles heal of cancer. Science 2002; 297: 63–4..
- 26PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 1998; 17: 6527–40., , et al .
- 27UnPAKing the class differences among p21-activated kinases. Trends Biochem Sci 2008; 33: 394–403., , ,
- 28PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol Cell Biol 2003; 23: 7122–33., , et al .
- 29Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol Cell Biol 2001; 21: 3523–33., , , , ,
- 30The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol Cancer Res 2008; 6: 1215–24., , et al .
- 31Pak4 induces premature senescence via a pathway requiring p16INK4/p19ARF and mitogen-activated protein kinase signaling. Methods Mol Biol 2005; 25: 9532–42., , ,
- 32The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem 2001; 276: 14414–9., ,